• Author: Meyeon Park
Clear all

Sodium-glucose cotransporter-2 inhibitor therapy and longitudinal changes in kidney function among Veterans with autosomal dominant polycystic kidney disease

Abstract: Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are a pillar of kidney disease therapy, but their efficacy remains unknown in autosomal dominant …